ValOre Metals Corp. has signed a Memorandum of Understanding with the German Federal Institute for Geosciences and Natural Resources (BGR) to collaborate on innovative, low-emission processing technologies for platinum group elements at its Pedra Branca project in Brazil. This partnership is part of the German government-funded BioPlat research project, focusing on bioleaching and hydrometallurgical methods to improve extraction from weathered PGE ores. The collaboration aims to advance sustainable mineral processing techniques over the next five years, leveraging expertise from German institutions to enhance ValOre's ongoing metallurgical work. This initiative could help address critical raw material supply gaps, especially palladium, benefiting both Brazil and Germany.
ValOre Metals Corp.'s new collaboration with the German Federal Institute for Geosciences and Natural Resources offers context for readers interested in mineral processing innovations. For readers following the Basic Materials sector, here is Pluang's market snapshot as of Nov 10, 2026 18:41 WIB: out of 83 priced US stocks, 26 rose and 54 fell. Notable movers include Harmony Gold Mining Co. at USD 17.02 with a 3.30% decline and Americas Gold and Silver Corporation at USD 3.19, down 3.04%.
The 2026 Verizon Data Breach Investigations Report links 61% of manufacturing breaches to third parties and 81% to internal data compromise. Manufacturers adopting Microsoft 365 Copilot should carefully manage which engineering and supplier files emp...
Soleo Health has been selected as a specialty pharmacy partner for Pasatru™ (garetosmab-grts), Regeneron's FDA-approved treatment for adults with fibrodysplasia ossificans progressiva (FOP), an ultra-rare genetic disorder. Pasatru™ is the first treat...
PsiThera raised $25 million in financing led by new investors AbbVie Ventures and Lumination Capital, alongside existing backers. The funds will support development of its oral small molecule TNFα inhibitor and advance its oral TL1A inhibitors into l...
Opus Genetics announced its Q3 2026 financial results and significant progress in its gene therapy programs for inherited retinal diseases. Key milestones include completion of dosing in OPGx-BEST1 Cohort 2 with data expected in Q1 2027, full enrollm...
Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...
